Yuji Hotta Selected Research

Accessory Nerve Injuries

6/2021	Detrusor underactivity causes neurogenic voiding dysfunction in a rat bilateral accessory nerve-injury model.
1/2021	Impairment of accessory nerves around major pelvic ganglion leading to overflow urinary incontinence in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuji Hotta Research Topics

Disease

15	Erectile Dysfunction 04/2022 - 03/2011
4	Neoplasms (Cancer) 04/2022 - 01/2018
4	Inflammation (Inflammations) 01/2021 - 12/2017
3	Hypertension (High Blood Pressure) 01/2020 - 11/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 01/2019
2	Disease Progression 01/2022 - 01/2019
2	Fibrosis (Cirrhosis) 10/2021 - 01/2020
2	Accessory Nerve Injuries 06/2021 - 01/2021
2	Multiple Myeloma 11/2020 - 01/2020
2	Tumor Lysis Syndrome 11/2020 - 01/2020
2	Ischemia 01/2020 - 01/2012
2	Carcinoma (Carcinomatosis) 01/2018 - 05/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 06/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2022
1	Fibrosarcoma 11/2021
1	Acute Kidney Injury (Acute Renal Failure) 11/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Underactive Urinary Bladder 06/2021
1	Ganglion Cysts (Ganglion) 01/2021
1	Colitis 01/2021
1	Lower Urinary Tract Symptoms 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2020
1	Hepatitis B 01/2018
1	Infections 01/2018
1	Neutropenia 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Solitary Kidney 05/2017
1	Metabolic Diseases (Metabolic Disease) 03/2017
1	Propionic Acidemia 03/2017
1	Type 2 Diabetes Mellitus (MODY) 04/2014

Drug/Important Bio-Agent (IBA)

3	Bortezomib (Velcade)FDA Link 11/2020 - 01/2018
3	SaltsIBA 01/2020 - 11/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2022 - 01/2018
2	Tadalafil (Cialis)FDA Link 06/2022 - 01/2020
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 04/2022 - 10/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2022 - 01/2021
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2022 - 10/2019
2	Nitric Oxide DonorsIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
2	salicylhydroxamic acid (SHAM)IBA 06/2021 - 01/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 01/2020
2	NADP (NADPH)IBA 01/2021 - 01/2020
2	Arginine (L-Arginine)FDA Link 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2020
2	Phosphodiesterase 5 InhibitorsIBA 01/2020 - 03/2011
2	Testosterone (Sustanon)FDA Link 10/2019 - 12/2017
2	Gemcitabine FDA Link 01/2018 - 05/2017
2	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2017 - 01/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017 - 04/2014
2	CitrullineIBA 06/2014 - 10/2013
2	Vardenafil Dihydrochloride (Levitra)FDA Link 07/2012 - 03/2011
1	gosha-jinki-ganIBA 04/2022
1	PlatinumIBA 04/2022
1	Phosphotransferases (Kinase)IBA 11/2021
1	Pharmaceutical PreparationsIBA 11/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021
1	MitogensIBA 11/2021
1	rho-Associated KinasesIBA 10/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2021
1	InterleukinsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2021
1	Proteasome InhibitorsIBA 11/2020
1	CreatinineIBA 01/2020
1	Thalidomide (Thalomid)FDA Link 01/2020
1	Lenalidomide (CC 5013)FDA Link 01/2020
1	Superoxide Dismutase-1IBA 01/2020
1	anagliptinIBA 01/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018
1	Drug CombinationsIBA 01/2018
1	Azacitidine (5 Azacytidine)FDA Link 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Everolimus FDA Link 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	taxaneIBA 01/2018
1	fludarabineIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 05/2017
1	Propionyl-Coenzyme A Carboxylase (Propionyl CoA Carboxylase)IBA 03/2017
1	propionyl-coenzyme A (propionyl-CoA)IBA 03/2017
1	Coenzyme A (CoA)IBA 03/2017
1	methylmalonyl-coenzyme A (methylmalonyl CoA)IBA 03/2017
1	AndrogensIBA 04/2014
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2012

Therapy/Procedure

7	Therapeutics 11/2021 - 04/2014
5	Drug Therapy (Chemotherapy) 11/2021 - 05/2017
1	Renal Dialysis (Hemodialysis) 01/2018
1	Antineoplastic Combined Chemotherapy Protocols 01/2018
1	Nephroureterectomy 05/2017
1	Ligation 01/2012